Skeletal myoblast sheet transplantation improves the diastolic function of a pressure-overloaded right heart
- PMID: 19619796
- DOI: 10.1016/j.jtcvs.2009.02.018
Skeletal myoblast sheet transplantation improves the diastolic function of a pressure-overloaded right heart
Abstract
Objective: The development of right ventricular dysfunction has become a common problem after surgical repair of complex congenital heart disease. A recent study reported that tissue-engineered skeletal myoblast sheet transplantation improves left ventricular function in patients with dilated and ischemic cardiomyopathy. Therefore myoblast sheet transplantation might also improve ventricular performance in a rat model of a pressure-overloaded right ventricle.
Methods: Seven-week-old male Lewis rats underwent pulmonary artery banding. Four weeks after pulmonary artery banding, myoblast sheet transplantation to the right ventricle was performed in the myoblast sheet transplantation group (n = 20), whereas a sham operation was performed in the sham group (n = 20).
Results: Four weeks after performing the procedure, a hemodynamic assessment with a pressure-volume loop showed a compensatory increase in systolic function in both groups. However, only the myoblast sheet transplantation group showed a significant improvement in the diastolic function: end-diastolic pressure (sham vs myoblast sheet transplantation, 10.3 +/- 3.1 vs 5.0 +/- 3.7 mm Hg; P < .001), time constant of isovolumic relaxation (11.1 +/- 2.5 vs 7.6 +/- 1.2 ms, P < .001), and end-diastolic pressure-volume relationship (16.1 +/- 4.5 vs 7.6 +/- 2.4/mL, P < .005). The right ventricular weight and cell size similarly increased in both groups. A histologic assessment demonstrated significantly suppressed ventricular fibrosis and increased capillary density in the myoblast sheet transplantation group in comparison with those in the sham group. Reverse transcription-polymerase chain reaction demonstrated an increased myocardial gene expression of hepatocyte growth factor and vascular endothelial growth factor in the myoblast sheet transplantation group but not in the sham group.
Conclusions: Skeletal myoblast sheet transplantation improved the diastolic dysfunction and suppressed ventricular fibrosis with increased capillary density in a rat model of a pressure-overloaded right ventricle. This method might become a novel strategy for the myocardial regeneration of right ventricular failure in patients with congenital heart disease.
Similar articles
-
Effects of transplanted myoblasts transfected with human growth hormone gene on improvement of ventricular function of rats.Chin Med J (Engl). 2008 Feb 20;121(4):347-54. Chin Med J (Engl). 2008. PMID: 18304469
-
Correlation of autologous skeletal myoblast survival with changes in left ventricular remodeling in dilated ischemic heart failure.J Thorac Cardiovasc Surg. 2005 Oct;130(4):1001. doi: 10.1016/j.jtcvs.2005.02.030. Epub 2005 Sep 2. J Thorac Cardiovasc Surg. 2005. PMID: 16214511
-
Autologous skeletal myoblast transplantation improved hemodynamics and left ventricular function in chronic heart failure dogs.J Heart Lung Transplant. 2005 Nov;24(11):1940-9. doi: 10.1016/j.healun.2005.02.024. Epub 2005 Aug 24. J Heart Lung Transplant. 2005. PMID: 16297802
-
The left heart can only be as good as the right heart: determinants of function and dysfunction of the right ventricle.Crit Care Resusc. 2007 Dec;9(4):344-51. Crit Care Resusc. 2007. PMID: 18052899 Review.
-
The ventricular septum: the lion of right ventricular function, and its impact on right ventricular restoration.Eur J Cardiothorac Surg. 2006 Apr;29 Suppl 1:S272-8. doi: 10.1016/j.ejcts.2006.02.011. Epub 2006 Mar 29. Eur J Cardiothorac Surg. 2006. PMID: 16567103 Review.
Cited by
-
Cell therapies for heart function recovery: focus on myocardial tissue engineering and nanotechnologies.Cardiol Res Pract. 2012;2012:971614. doi: 10.1155/2012/971614. Epub 2012 Apr 22. Cardiol Res Pract. 2012. PMID: 22577591 Free PMC article.
-
Engineered Tissue for Cardiac Regeneration: Current Status and Future Perspectives.Bioengineering (Basel). 2022 Oct 22;9(11):605. doi: 10.3390/bioengineering9110605. Bioengineering (Basel). 2022. PMID: 36354516 Free PMC article. Review.
-
Engineered fetal cardiac graft preserves its cardiomyocyte proliferation within postinfarcted myocardium and sustains cardiac function.Tissue Eng Part A. 2011 Mar;17(5-6):585-96. doi: 10.1089/ten.TEA.2010.0259. Epub 2011 Jan 16. Tissue Eng Part A. 2011. PMID: 20868205 Free PMC article.
-
Can't Patch Everything: Personalized Medicine for Cell Therapy in Dilated Cardiomyopathy.J Am Heart Assoc. 2021 Jul 6;10(13):e021867. doi: 10.1161/JAHA.121.021867. Epub 2021 Jul 2. J Am Heart Assoc. 2021. PMID: 34212767 Free PMC article. No abstract available.
-
Xenogeneic and Stem Cell-Based Therapy for Cardiovascular Diseases: Genetic Engineering of Porcine Cells and Their Applications in Heart Regeneration.Int J Mol Sci. 2020 Dec 18;21(24):9686. doi: 10.3390/ijms21249686. Int J Mol Sci. 2020. PMID: 33353186 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources